Academic Journal
New and Updated Results from a Multicenter, Open-Label, Global Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R+CT) (ALLELE)
| العنوان: | New and Updated Results from a Multicenter, Open-Label, Global Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R+CT) (ALLELE) |
|---|---|
| المؤلفون: | Beitinjaneh, Amer, Baiocchi, Robert, Chaganti, Sridhar, Choquet, Sylvain, Dierickx, Daan, Dinavahi, Rajani, Gamelin, Laurence, Ghobadi, Armin, Guzman-Becerra, Norma, Joshi, AJ, Mahadeo, Kris Michael, Mehta, Dr. Aditi, Nikiforow, Sarah, Reshef, Ran, Ye, Wei, Prockop, Susan |
| المصدر: | Transplantation and Cellular Therapy ; volume 29, issue 2, page S21-S22 ; ISSN 2666-6367 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s2666-6367(23)00094-5 |
| الاتاحة: | http://dx.doi.org/10.1016/s2666-6367(23)00094-5 https://api.elsevier.com/content/article/PII:S2666636723000945?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S2666636723000945?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| رقم الانضمام: | edsbas.9D2AD840 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s2666-6367(23)00094-5 |
|---|